What side effects are associated with this type of intervention?

The most common side effects of treatments involving AI-driven support systems, such as those studied in the ChatGPT trial, include user-reported issues like information overload, potential inaccuracies in provided information, and occasional frustration due to miscommunication or misunderstanding by the AI. Additionally, there may be concerns about data privacy and the emotional impact of interacting with non-human entities for support.

What prior FDA approvals exist?

There are no FDA-approved treatments specifically for Artificial Intelligence as it is not a medical condition. However, AI technologies are increasingly being integrated into healthcare to provide information, support, and guidance. These applications include AI-driven diagnostic tools, virtual health assistants, and decision support systems. While these technologies are not drugs, they are subject to regulatory oversight to ensure safety and efficacy in their supportive roles in healthcare.

What other types of research exist?

Promising alternatives to ChatGPT for AI-driven patient support in 2024 include: 1) IBM Watson Health, known for its advanced data analytics and personalized treatment recommendations; 2) Google's DeepMind Health, which leverages deep learning for predictive analytics and diagnostics; 3) Microsoft's Azure Health Bot, offering robust integration with healthcare systems and personalized patient interactions; and 4) Babylon Health, which uses AI for symptom checking, virtual consultations, and health monitoring.

← Back to Search

ChatGPT for Educational Activities in Health Sciences Students (AIHSS Trial)

N/A

Waitlist Available

Led By Mirella Veras, PhD

Research Sponsored by Carleton University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Unable to provide informed consent

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 24 hours

Awards & highlights

No Placebo-Only Group

Summary

This trial tests ChatGPT, a smart assistant, to help health sciences students at Carleton University with their assignments. It compares ChatGPT's effectiveness to regular online resources by seeing which method helps students learn better.

Who is the study for?

This trial is for health science students enrolled in the HLTH 3503 course, focusing on Chronic Health Conditions and Disability for Fall 2023. Participants must be able to give informed consent. Those who cannot provide this consent are excluded.

What is being tested?

The study is testing the effectiveness of ChatGPT as an educational tool against usual online resources. It's a crossover randomized control trial where students are randomly placed into two groups: one using ChatGPT and another with standard materials.

What are the potential side effects?

Since this trial involves educational tools rather than medical interventions, 'side effects' may include differences in learning outcomes or preferences rather than physical symptoms.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 24 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 24 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 24 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

System Usability Scale (SUS) scores are 0-100,The average SUS score is 68.

Secondary study objectives

Student's perception of artificial intelligence, questionnaire reviwed by experts, No recognised gold standard measurement for outcome.

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Artificial Intelligence (ChatGPT) GroupExperimental Treatment1 Intervention

Participants in Group A will be assigned to utilize ChatGPT as their tool to complete assignments. They will be given a period of six days to utilize artificial intelligence through ChatGPT for assignment completion. Along with the assignment instructions, participants will receive an ethical guideline and specific guidelines on how to effectively utilize ChatGPT. Once the intervention period is concluded, participants will be given a 24-hour window to complete a survey that assesses the usability of the technology. The survey aims to gather valuable feedback on the participants' experience and perception of using ChatGPT for their assignments. In addition, participants in Arm 1 will also be asked to fill out a survey regarding their perception of using artificial intelligence (AI) as an assistance tool to complete their assignments. This survey aims to gather insights into their thoughts, opinions, and attitudes towards utilizing AI in the learning process

Group II: Traditional Online tools GroupActive Control1 Intervention

Group B will serve as the control group in this study. Participants in this group will receive instructions on how to complete the assignment using traditional online tools available on the internet, without the use of artificial intelligence. They will have a timeframe of six days to complete the assignment using these conventional tools. Similar to participants in Arm 1, they will also be required to fill out a survey on technology usability, providing feedback on their experience with the online tools.

0 / 1Eligibility criteria met

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

The most common treatments involving Artificial Intelligence, such as those studied in the ChatGPT trial, primarily focus on providing information, support, and guidance. These AI systems use natural language processing and machine learning algorithms to understand and respond to patient queries, offering personalized advice and emotional support. This matters for patients as it enhances accessibility to reliable health information, supports decision-making, and can provide timely emotional support, potentially improving overall patient outcomes and satisfaction.

Application of Artificial Intelligence on Psychological Interventions and Diagnosis: An Overview.Future thinking to decrease real-world drinking in alcohol use disorder: Repairing reinforcer pathology in a randomized proof-of-concept trial.